Goldman Sachs’s Kronos Bio KRON Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-12,238
| Closed | -$10.1K | – | 5264 |
|
|
2025
Q1 | $10.1K | Sell |
12,238
-5,805
| -32% | -$4.79K | ﹤0.01% | 5003 |
|
|
2024
Q4 | $17.1K | Sell |
18,043
-3,647
| -17% | -$3.47K | ﹤0.01% | 4925 |
|
|
2024
Q3 | $21.7K | Buy |
21,690
+3,905
| +22% | +$3.91K | ﹤0.01% | 4699 |
|
|
2024
Q2 | $22.1K | Sell |
17,785
-110
| -0.6% | -$136 | ﹤0.01% | 4605 |
|
|
2024
Q1 | $23.3K | Sell |
17,895
-1,748
| -9% | -$2.27K | ﹤0.01% | 4598 |
|
|
2023
Q4 | $24.6K | Sell |
19,643
-7,769
| -28% | -$9.71K | ﹤0.01% | 4599 |
|
|
2023
Q3 | $35.6K | Sell |
27,412
-7,413
| -21% | -$9.64K | ﹤0.01% | 4516 |
|
|
2023
Q2 | $59.9K | Sell |
34,825
-162,145
| -82% | -$279K | ﹤0.01% | 4651 |
|
|
2023
Q1 | $288K | Sell |
196,970
-4,454
| -2% | -$6.5K | ﹤0.01% | 4362 |
|
|
2022
Q4 | $326K | Sell |
201,424
-68,361
| -25% | -$111K | ﹤0.01% | 4308 |
|
|
2022
Q3 | $904K | Sell |
269,785
-147,457
| -35% | -$494K | ﹤0.01% | 3893 |
|
|
2022
Q2 | $1.52M | Buy |
417,242
+207,417
| +99% | +$755K | ﹤0.01% | 3660 |
|
|
2022
Q1 | $1.52M | Buy |
209,825
+43,265
| +26% | +$313K | ﹤0.01% | 3783 |
|
|
2021
Q4 | $2.26M | Buy |
166,560
+50,071
| +43% | +$681K | ﹤0.01% | 3418 |
|
|
2021
Q3 | $2.44M | Buy |
116,489
+88,325
| +314% | +$1.85M | ﹤0.01% | 3317 |
|
|
2021
Q2 | $674K | Buy |
28,164
+9,684
| +52% | +$232K | ﹤0.01% | 4262 |
|
|
2021
Q1 | $541K | Sell |
18,480
-24,051
| -57% | -$704K | ﹤0.01% | 4301 |
|
|
2020
Q4 | $1.27M | Buy |
+42,531
| New | +$1.27M | ﹤0.01% | 3326 |
|